Clinical trial
Evaluating the Safety and Efficacy of Injectable Combination Klotho and Follistatin Plasmid Gene Therapy in Humans -- An Interventional, Non-Placebo Controlled Pilot Phase Study
NCT07285629 is registered in ClinicalTrials.gov with Minicircle as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Safety and Efficacy of Injectable Combination Klotho and Follistatin Plasmid Gene Therapy in Humans -- An Interventional, Non-Placebo Controlled Pilot Phase Study
- Lead sponsor
- Minicircle
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 16, 2025
- Completion date
- April 30, 2026
- Enrollment
- 14 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
healthy adults